|
Delayed
BURSA MALAYSIA
04:50:02 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.6700 MYR | 0.00% |
|
0.00% | -2.90% |
| Market Cap | 148M 36.31M 32.05M 30.32M 27.5M 51.56M 3.48B 52.06M 364M 140M 1.78B 136M 133M 5.73B | P/E 2026 * |
9.52x | P/E 2027 * | 9.01x |
|---|---|---|---|---|---|
| Enterprise Value | 148M 36.31M 32.05M 30.32M 27.5M 51.56M 3.48B 52.06M 364M 140M 1.78B 136M 133M 5.73B | EV / Sales 2026 * |
0.61x | EV / Sales 2027 * | 0.56x |
| Free-Float |
15.96% | Yield 2026 * |
3.73% | Yield 2027 * | 4.03% |
| Current month | -2.19% | ||
| 1 month | -2.19% | ||
| 3 months | +1.52% | ||
| 6 months | -2.90% | ||
| Current year | -2.90% |
| 1 week | 0.67 | 0.67 | |
| 1 month | 0.66 | 0.68 | |
| Current year | 0.62 | 0.72 | |
| 1 year | 0.62 | 0.72 | |
| 3 years | 0.58 | 0.8 | |
| 5 years | 0.58 | 0.8 | |
| 10 years | 0.57 | 1.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ban Keong Lim
CEO | Chief Executive Officer | 55 | 2015-03-31 |
Yan San Chan
DFI | Director of Finance/CFO | 56 | 2013-12-31 |
| Chief Operating Officer | 38 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 2015-03-31 | |
Ban Keong Lim
BRD | Director/Board Member | 55 | 2015-03-31 |
Kam Weng Foong
BRD | Director/Board Member | 66 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/31/25 | Buy | Chief Executive Officer | 110,000 | 0.0497% | ||
| 9/22/23 | Buy | Chief Executive Officer | 17,000 | 0.0077% | ||
| 9/8/23 | Buy | Chief Executive Officer | 103,000 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -1.47% | -2.90% | 36.32M | ||
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | ||
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | ||
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | ||
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | ||
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | ||
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | ||
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | ||
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | ||
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | ||
| Average | -0.17% | +0.01% | +25.80% | +44.49% | 364.29B | |
| Weighted average by Cap. | -0.05% | +0.42% | +38.91% | +70.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 244M 59.66M 52.65M 49.82M 45.18M 84.7M 5.73B 85.54M 598M 230M 2.92B 224M 219M 9.41B | 265M 64.98M 57.34M 54.26M 49.2M 92.25M 6.24B 93.16M 651M 251M 3.18B 244M 239M 10.25B |
| Net income | 15.6M 3.82M 3.37M 3.19M 2.89M 5.42M 367M 5.48M 38.27M 14.75M 187M 14.35M 14.03M 602M | 15.6M 3.82M 3.37M 3.19M 2.89M 5.42M 367M 5.48M 38.27M 14.75M 187M 14.35M 14.03M 602M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | MYR 0.6700 | 0.00% | 7,000 |
| 26-09-24 | MYR 0.6700 | 0.00% | 23,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 5278 Stock
Select your edition
All financial news and data tailored to specific country editions
















